Payers' Perspectives on Pharmacist-Directed Care in a Community Pharmacy Setting.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching IS 10600280 AND DT 2019 AND VI 53 AND IP 9
Results: 15
1
2
Evaluation of Lactation Compatibility Reference Recommendations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Unrecognized Drug Interaction: Ranolazine Adverse Effects Intensified by Darunavir-Cobicistat.
- Published in:
- 2019
- By:
- Publication type:
- Letter
5
Responding to Manuscript Reviewer and Editor Comments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
6
Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System.
- Published in:
- 2019
- By:
- Publication type:
- Letter
7
A Pseudo-False Negative Urine Methadone Screen in a Patient Treated With Rifampin.
- Published in:
- 2019
- By:
- Publication type:
- Letter
8
Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
- Published in:
- 2019
- By:
- Publication type:
- journal article
9
Evaluation of Pharmacist Impact Within an Interdisciplinary Inpatient Heart Failure Consult Service.
- Published in:
- 2019
- By:
- Publication type:
- journal article
10
Incidence of Acute Kidney Injury in Intermittent Versus Continuous Infusion of Polymyxin B in Hospitalized Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
11
Intravenous Insulin Infusion Protocol Compared With Subcutaneous Insulin for the Management of Hyperglycemia in Critically Ill Adults.
- Published in:
- 2019
- By:
- Publication type:
- journal article
12
Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
13
Copanlisib: An Intravenous Phosphatidylinositol 3-Kinase (PI3K) Inhibitor for the Treatment of Relapsed Follicular Lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
14
Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent.
- Published in:
- 2019
- By:
- Publication type:
- journal article
15
Erenumab: A First-in-Class Monoclonal Antibody for Migraine Prevention.
- Published in:
- 2019
- By:
- Publication type:
- journal article